2566627

Source:http://linkedlifedata.com/resource/pubmed/id/2566627

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001554, umls-concept:C0015046, umls-concept:C0201734, umls-concept:C0556984, umls-concept:C0702073, umls-concept:C2699007
pubmed:issue	3
pubmed:dateCreated	1989-7-5
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0366372
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Hydantoins
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	0091-2700
pubmed:author	pubmed-author:BrowneT RTR, pubmed-author:SzaboG KGK
pubmed:issnType	Print
pubmed:volume	29
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	270-1
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:2566627-Drug Administration Schedule, pubmed-meshheading:2566627-Half-Life, pubmed-meshheading:2566627-Humans, pubmed-meshheading:2566627-Hydantoins, pubmed-meshheading:2566627-Metabolic Clearance Rate
pubmed:year	1989
pubmed:articleTitle	A pharmacokinetic rationale for three times daily administration of ethotoin (Peganone).
pubmed:affiliation	Department of Neurology, Boston University School of Medicine, MA.
pubmed:publicationType	Journal Article, Research Support, U.S. Gov't, Non-P.H.S.